Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYStatistics in medicine

Using Joint Models in Phase I Dose‐Finding Designs in Oncology: Considerations for Frequentist Approaches

  1. 1University of Cambridge

Related

  1. Negative controls for bias detection within exposure-anchored self-controlled designs: applications and considerations
    Tu P H Trang, Marloes T Bazelier, Olaf H Klungel +4
    International journal of epidemiologyPeer-reviewedCC BYFull textStatisticsEurope PMCEurope PMC
  2. Combining Adaptive Seamless Phase II/III Designs and Group Sequential Analysis for Time-to-Event Endpoints in Oncology Trials
    Wentian Guo, Qingyu Chen, Chi Song +4
    arXivPreprintCC BY 4.0Full textStatisticsarXiv
  3. Frequentist prediction intervals for random-effects meta-analysis via confidence-distribution propagation
    Hisashi Noma, Guido Schwarzer
    arXivPreprintCC BY 4.0Full textStatisticsarXiv
  4. RECAP: Representation-Based Calibration with Amortized Pooling for Frequentist Simulation-Based Inference
    Runshi Tang, Genevera I. Allen
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  5. Inconsistency between Frequentist and Bayesian inference, approximation of improper priors and permissible priors
    Pierre Druilhet, Erwan Saint Loubert Bié
    arXivPreprintarXiv licenceFull textStatisticsarXiv
BibTeX
@article{chen2026using,
  title = {{Using Joint Models in Phase I Dose‐Finding Designs in Oncology: Considerations for Frequentist Approaches}},
  author = {Xijin Chen and Pavel Mozgunov and Richard D. Baird and Thomas Jaki},
  journal = {Statistics in medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13659646},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Using Joint Models in Phase I Dose‐Finding Designs in Oncology: Considerations for Frequentist Approaches
AU  - Xijin Chen
AU  - Pavel Mozgunov
AU  - Richard D. Baird
AU  - Thomas Jaki
PY  - 2026
DA  - 2026/10/01
JO  - Statistics in medicine
UR  - https://europepmc.org/article/PMC/PMC13659646
SN  - 0277-6715
SN  - 1097-0258
ER  -